Skip to main content
Netherlands Heart Journal logoLink to Netherlands Heart Journal
. 2006 Mar;14(3):95-98, 99.

Rationale of the REPARATOR study

A randomised trial with serial cardiac MRI follow-up testing the ability of atorvastatin to reduce reperfusion damage after primary PCI for acute MI

FD Eefting, MJ Cramer, PRS Stella, BJ Rensing, PA Doevendans
PMCID: PMC2557272  PMID: 25696602

Abstract

The REPARATOR study is a multicentre clinical trial in which the effect of 80 mg atorvastatin on microvascular (re)perfusion and late ventricular remodelling, and infarct size in patients presenting with an acute ST-elevation myocardial infarction is studied. Primary endpoint is end-systolic volume index at three months measured by quantitative cine magnetic resonance imaging (MRI). Secondary endpoints are cardiac MI (CMR) measurements of global and regional left ventricular function, MRI measurements of infarct size on admission, one week and three months as well as changes between MRI investigations, biochemical markers of infarct size, blush grade, and TIMI frame count. A total of 50 patients will be enrolled. Including three months follow-up, the study will last for six months.

Full text

PDF

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bell Robert M., Yellon Derek M. Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway. J Am Coll Cardiol. 2003 Feb 5;41(3):508–515. doi: 10.1016/s0735-1097(02)02816-4. [DOI] [PubMed] [Google Scholar]
  2. Cannon Christopher P., Braunwald Eugene, McCabe Carolyn H., Rader Daniel J., Rouleau Jean L., Belder Rene, Joyal Steven V., Hill Karen A., Pfeffer Marc A., Skene Allan M. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004 Mar 8;350(15):1495–1504. doi: 10.1056/NEJMoa040583. [DOI] [PubMed] [Google Scholar]
  3. Choi K. M., Kim R. J., Gubernikoff G., Vargas J. D., Parker M., Judd R. M. Transmural extent of acute myocardial infarction predicts long-term improvement in contractile function. Circulation. 2001 Sep 4;104(10):1101–1107. doi: 10.1161/hc3501.096798. [DOI] [PubMed] [Google Scholar]
  4. Grothues Frank, Smith Gillian C., Moon James C. C., Bellenger Nicholas G., Collins Peter, Klein Helmut U., Pennell Dudley J. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol. 2002 Jul 1;90(1):29–34. doi: 10.1016/s0002-9149(02)02381-0. [DOI] [PubMed] [Google Scholar]
  5. Hochman J. S., Choo H. Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation. 1987 Jan;75(1):299–306. doi: 10.1161/01.cir.75.1.299. [DOI] [PubMed] [Google Scholar]
  6. Holman E. R., Buller V. G., de Roos A., van der Geest R. J., Baur L. H., van der Laarse A., Bruschke A. V., Reiber J. H., van der Wall E. E. Detection and quantification of dysfunctional myocardium by magnetic resonance imaging. A new three-dimensional method for quantitative wall-thickening analysis. Circulation. 1997 Feb 18;95(4):924–931. doi: 10.1161/01.cir.95.4.924. [DOI] [PubMed] [Google Scholar]
  7. Kim R. J., Fieno D. S., Parrish T. B., Harris K., Chen E. L., Simonetti O., Bundy J., Finn J. P., Klocke F. J., Judd R. M. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999 Nov 9;100(19):1992–2002. doi: 10.1161/01.cir.100.19.1992. [DOI] [PubMed] [Google Scholar]
  8. Nissen Steven E., Tuzcu E. Murat, Schoenhagen Paul, Brown B. Greg, Ganz Peter, Vogel Robert A., Crowe Tim, Howard Gail, Cooper Christopher J., Brodie Bruce. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA. 2004 Mar 3;291(9):1071–1080. doi: 10.1001/jama.291.9.1071. [DOI] [PubMed] [Google Scholar]
  9. Pfeffer M. A., Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990 Apr;81(4):1161–1172. doi: 10.1161/01.cir.81.4.1161. [DOI] [PubMed] [Google Scholar]
  10. Schenck J. F. Safety of strong, static magnetic fields. J Magn Reson Imaging. 2000 Jul;12(1):2–19. doi: 10.1002/1522-2586(200007)12:1<2::aid-jmri2>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  11. Shellock F. G. Radiofrequency energy-induced heating during MR procedures: a review. J Magn Reson Imaging. 2000 Jul;12(1):30–36. doi: 10.1002/1522-2586(200007)12:1<30::aid-jmri4>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  12. Sutton M. G., Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation. 2000 Jun 27;101(25):2981–2988. doi: 10.1161/01.cir.101.25.2981. [DOI] [PubMed] [Google Scholar]
  13. White H. D., Norris R. M., Brown M. A., Brandt P. W., Whitlock R. M., Wild C. J. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987 Jul;76(1):44–51. doi: 10.1161/01.cir.76.1.44. [DOI] [PubMed] [Google Scholar]
  14. Yellon D. M., Baxter G. F. Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: distant dream or near reality? Heart. 2000 Apr;83(4):381–387. doi: 10.1136/heart.83.4.381. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. van 't Hof A. W., Liem A., Suryapranata H., Hoorntje J. C., de Boer M. J., Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation. 1998 Jun 16;97(23):2302–2306. doi: 10.1161/01.cir.97.23.2302. [DOI] [PubMed] [Google Scholar]

Articles from Netherlands Heart Journal are provided here courtesy of Springer

RESOURCES